advanced search

Prefilled Syringes & Injection Devices83

Issue No #83  February 5th, 2018


Download PDF


Inside the magazine

INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
PREFILLED SYRINGES
SHL Medical
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
SHL details its latest offerings in the world of biologics, as well as its partnership with QuiO, a speciality digital healthcare start-up, to develop injectables in the connected healthcare space.
SUPERCAPSYRINGE<sup>®</sup> PASSES THE TEST
INJECTION
Hans Peter Manser
Weibel CDS
SUPERCAPSYRINGE® PASSES THE TEST
Hans Peter Manser, Lisa Lippuner and Sarah Raible discuss the findings of a study conducted to test the qualities of Weibel’s SuperCapSyringe®.
FROM PREFILLED SYRINGES TO COMBI-FILLING
EXPERT VIEW
Klaus Ullher
FROM PREFILLED SYRINGES TO COMBI-FILLING
Klaus Ullherr summarises the state of modern packaging technology in the pharmaceutical industry in the light of the biotech boom, ready-to-fill and pre-sterilised containers and the trend towards individualised healthcare.
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
PREFILLED SYRINGES
Pascal Dugand
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
Pascal Dugand relates a study conducted by Nemera to determine a way to optimise the transition from needle insertion to syringe emptying for parenteral devices. This piece was originally presented as a poster at PDA Vienna 2017.
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
PREFILLED SYRINGES
Alessio Bonati
SG Ompi
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
Alessio Bonati discusses the problematic interactions between drugs and their primary containers and goes on to introduce the Alba platform, Ompi’s range of primary glass containers designed to unify drug-container interactions over a product’s lifecycle.
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
PREFILLED SYRINGES
Claudia Petersen
Gerresheimer
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
Claudia Petersen looks at the technological advances being made to ensure prefillable syringes are compatible with protein-based, biotech-derived drugs.
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
INJECTION
Christoph Hammer
Dividella
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
Christoph Hammer gives an overview of the Industry 4.0 concept, and its pharmaceutical application Pharma 4.0. Furthermore, Mr Hammer provides examples of what Pharma 4.0 can offer, discussing solutions shown at Interpak 2017, Düsseldorf.
SUNDEEP KANKANALA, BD
INTERVIEW
Dr Sundeep Kankanala
BD (Becton Dickinson & Company)
SUNDEEP KANKANALA, BD
Sundeep Kankanala discusses the challenges faced by today’s biopharmaceutical industry, in particular those posed by the need for large volumes and the issues caused by the use of silicone in prefilled syringes.
A NOVEL PRECISION-TARGETED ENDOVASCULAR DELIVERY SYSTEM
INJECTION
Paul J Fitzpatrick
Advanced Catheter Therapies
A NOVEL PRECISION-TARGETED ENDOVASCULAR DELIVERY SYSTEM
Paul J Fitzpatrick introduces the Occlusion Perfusion Catheter™, an innovative device that can target high concentrations of drug to precisely defined locations.
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
PREFILLED SYRINGES
Bill Welch
Phillips-Medisize
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
There are some device design considerations that are common across the spectrum of biologics development. Bill Welch discusses these considerations, highlighting the advantage conferred by accounting for them early in the product lifecycle.
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
INTERVIEW
John Merhige
Credence MedSystems
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.
RECONSTITUTION DEVICES: MIXING, POWER, PACKAGING & REGULATION
EXPERT VIEW
Charlotte Harvey
RECONSTITUTION DEVICES: MIXING, POWER, PACKAGING & REGULATION
Charlotte Harvey discusses the challenge of reconstituting lyophilised drugs, both from the perspective of the drug itself and the delivery device associated with it.
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
PREFILLED SYRINGES
Dr Karen Guerrero
BD (Becton Dickinson & Company)
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
Karen Guerrero outlines how human factors engineering, now an essential requirement for all new drug delivery combination product approvals, can represent a significant challenge and how BD can help streamline this aspect of the development process.
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
PREFILLED SYRINGES
Dr Jakob Lange
Ypsomed
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
Orfeo Niedermann and Jakob Lange provide insights into the development of platform products that offer pharma companies low risks and shorter timelines at an attractive cost, using the examples of the YpsoMate autoinjector and UnoPen pen injector platform products.
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
EXPERT VIEW
Karl Hewson
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
Karl Hewson and Uri Baruch discuss the challenges presented by chronic illness, and look ahead to a better future of patient-centric treatment, personalised to each individual’s needs.
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
PREFILLED SYRINGES
Paul Sullivan
Noble
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
Paul Sullivan outlines how the growing trend towards patient self-injection, outside of the clinical setting, places an ever greater emphasis on quality training and onboarding. Mr Sullivan specifically explains how such training can help overcome the issue of patient needle fear or anxiety.
Top